Additional studies in preferably incident patients, with an adequate PTH suppression in the intervention groups and during a longer period, are required to test the beneficial effects of active vitamin D<sub>3</sub> over no treatment and to investigate whether in 25(OH)D<sub>3</sub>-deficient PD patients the type of active vitamin D<sub>3</sub> matters.
MicroRNAs (miRNAs) have been identified as useful biomarkers in various diseases, and the aim of this study was to identify miRNAs associated with parathyroid hormone level in peritoneal dialysis (PD) patients.